跳至主要内容
临床试验/NCT02223715
NCT02223715已完成不适用

A Prospective Study to Characterize the Management and Outcome of Clostridium Difficile Infection (CDI) in Asian Pacific Countries

Otsuka Pharmaceutical Co., Ltd.0 个研究点目标入组 600 人开始时间: 2014年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
600
主要终点
Status at the End of CDI Episode

研究概览

简要总结

The aim of this study is to conduct an Asia-Pacific, multi-center, prospective observational study to characterize patients with CDI as well as to understand treatment and management of the disease.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with a confirmed diagnosis of CDI, as documented by diarrheal symptoms and positive stool test result for CDT or toxigenic C. difficile, or colonoscopic findings of PMC
  • Patients and/or legal guardian willing to provide informed consent and/or informed assent or data release, according to local regulations

排除标准

  • Patients with diarrheal symptoms caused by bacteria other than C. difficile, such as Salmonella, Campylobacter, Vibrio, Shigella, and Escherichia coli.

结局指标

主要结局

Status at the End of CDI Episode

时间窗: From the time of CDI diagnosis to the end of the treatment

The patients were observed from the diagnosis to the end of the treatment and got a telephone follow up call after two month from the end of treatment. The categories of the status indicating below are at the end of the treatment, not at the follow up call. Lost to follow-up means the patient number who were lost during the treatment course.

Patient Demographics

时间窗: At the study at the time of CDI diagnosis enrollment

Medical history is information which was collected at the CDI diagnosis in this study. The items of the Medical history are indicated below. Concomitant diseases at the CDI diagnosis were included in the Medical history.

次要结局

  • Clinical Complication(From the time of CDI diagnosis to recovery or recurrence)
  • Recurrence or Not After 2 Months Follow-up(From the time of CDI diagnosis to 2 months follow-up)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验